Novavax Inc risk profile
44 Elevated one input has moved against it
Measured 21 October 2026 from NVAX's filed statements. Recomputed nightly.
44 (Elevated), driven by Cash conversion at 100, over 6 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 53 | Elevated | Volatile | One-year price volatility — 70.4% |
| Operating pressure | Reads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company. | |||
| Cash conversion | 100 | Acute | Stable | Capital spending against operating cash — -0.03x |
| Leverage and coverage | 7 | Contained | Easing | Current ratio — 2.13x |
| Competitive position | 41 | Elevated | Stable | Revenue-growth gap against peers — -79.3 percentage points |
| Concentration | 78 | Stretched | Easing | Customer concentration — 3,897 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.